SCHEMBL3049341

SCHEMBL3049341

COC(=O)c1ccccc1S(=O)(=O)N1CCc2cc(S(N)(=O)=O)c(OC)cc2C1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.51
CA2 P00918 2/20 0.51
CA9 Q16790 2/20 0.51
CA5A P35218 1/20 0.51
CA7 P43166 2/20 0.51
PKM P14618 3/20 0.50
CYP19A1 P11511 1/20 0.50
AKR1C3 P42330 1/20 0.49
ALDH1A1 P00352 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
FNTA P49354 1/20 0.47
FNTB P49356 1/20 0.47
POLB P06746 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
CYP3A4 P08684 1/20 0.44
CYP2C19 P33261 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
CA14 Q9ULX7 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3061701 0.90 PKM (0.52) CA7PKMCYP19A1AKR1C3ALDH1A1
SCHEMBL3059012 0.86 CA7 (0.59) CA1CA2CA9CA7PKM
SCHEMBL3061681 0.83 CYP19A1 (0.57) PKMCYP19A1AKR1C3ALDH1A1SMN1; SMN2
SCHEMBL3046503 0.82 PKM (0.58) CA7PKMAKR1C3ALDH1A1SMN1; SMN2
SCHEMBL7076183 0.81 KMT2A (0.58) CA1CA2CA9CA5AAKR1C3
SCHEMBL3051585 0.79 PKM (0.80) CA1CA2CA9CA7PKM
SCHEMBL3049295 0.77 KDM4E (0.64) CA1CA2CA9CA7ALDH1A1
SCHEMBL3062599 0.76 CA7 (0.56) CA7PKMAKR1C3ALDH1A1SMN1; SMN2
SCHEMBL3062381 0.76 PKM (0.61) CA7PKMCYP19A1AKR1C3ALDH1A1
SCHEMBL3055914 0.76 AKR1C3 (0.60) CA7PKMCYP19A1AKR1C3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100222299-A1 COMPOUND STERIX LIMITED (GB) 2010-09-02 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100222299-A1 COMPOUND MKI67, VHL, MYC CA1 1200/4885CA2 1077/4885CA9 1002/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.